Laboratory of Molecular Biology of Pathogenic Fungi, Laboratory of Molecular Biology, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil
Auto-generated profile, based on publicly available information
Jéssica dos Santos Folha
Laboratory of Molecular Biology of Pathogenic Fungi, Laboratory of Molecular Biology, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil
Nonlytic exocytosis is a process in which previously ingested microbes are expelled from host phagocytes with the concomitant survival of both cell types. This process has been observed in the interaction of Cryptococcus spp. and other fungal cells with phagocytes as distant as mammalian, bird, and fish macrophages and ameboid predators. Despite a great amount of research dedicated to unraveling this process, there are still many questions about its regulation and its final benefits for host or fungal cells. During a study to characterize the virulence attributes of Brazilian clinical isolates of C. neoformans, we observed great variability in their rates of nonlytic exocytosis and noted a correlation between this process and fungal melanin production/laccase activity. Flow cytometry experiments using melanized cells, nonmelanized cells, and lac1Δ mutants revealed that laccase has a role in the process of nonlytic exocytosis that seems to be independent of melanin production. These results identify a role for laccase in virulence, independent of its role in pigment production, that represents a new variable in the regulation of nonlytic exocytosis. IMPORTANCECryptococcus neoformans is a yeast that causes severe disease, primarily in immunosuppressed people. It has many attributes that allow it to survive and cause disease, such as a polysaccharide capsule and the dark pigment melanin produced by the laccase enzyme. Upon infection, the yeast is ingested by cells called macrophages, whose function is to kill them. Instead, these fungal cells can exit from macrophages in a process called nonlytic exocytosis. We know that this process is controlled by both host and fungal factors, only some of which are known. As part of an ongoing study, we observed that C. neoformans isolates that produce melanin faster are more-frequent targets of nonlytic exocytosis. Further experiments showed that this is probably due to higher production of laccase, because fungi lacking this enzyme are nonlytically exocytosed less often. This shows that laccase is an important signal/regulator of nonlytic exocytosis of C. neoformans from macrophages.
24 June 2026 in Revista Brasileira de Ciência Aberta
This analysis addresses the interaction between gut microbiota and immunity in critically ill patients, emphasizing the importance of maintaining a healthy microbiome in these cases. It’s crucial to understand the functions of the microbiota and its relationship with immunity, identify key studies on the topic, and point out strategies to reduce complications in ICU patients. It’s observed that an imbalance in the gut microbiota, characterized by a decrease in bacterial diversity, promotes colonization by pathogenic bacteria. This state of dysbiosis can lead to bacterial translocation, where microorganisms and toxins cross the intestinal barrier, causing systemic inflammation. Furthermore, dysbiosis affects neurotransmitter production, impairing the immune response and worsening the clinical condition of patients. Modulating the gut microbiota through the use of probiotics, prebiotics, and other interventions can be a promising strategy to improve immunity and reduce complications in critically ill patients. These approaches have shown potential in restoring microbial diversity and promoting a more balanced immune state. However, more research is needed to deepen the understanding of this relationship and develop effective therapeutic interventions that can be implemented in clinical practice. Thus, understanding the gut microbiota can significantly contribute to improving the care of critically ill patients.